Sanofi (SNYNF) Minority Interest (2010 - 2025)
Sanofi's (SNYNF) quarterly Minority Interest came in at $570.4 million in Q4 2025, up 52.5% year-on-year from $374.0 million in Q4 2024, and up 85.94% quarter-over-quarter from $306.8 million in Q2 2025.
Sanofi (SNYNF) Minority Interest (2010 - 2025) Analysis & Trends
Sanofi has disclosed Minority Interest across 16 years of filings, most recently posting $570.4 million for Q4 2025.
- Minority Interest for Q4 2025 came in at $570.4 million, up 52.5% year-over-year; the trailing twelve-month figure through Dec 2025 was $570.4 million (up 52.5% YoY), and the FY2025 annual result was $570.4 million, up 52.5% from the prior year.
- Minority Interest came in at $570.4 million for Q4 2025 at Sanofi, up from $306.8 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $570.4 million in Q4 2025 to a low of $18.3 million in Q2 2024.
- The 5-year median for Minority Interest is $321.8 million (2023), against an average of $249.1 million.
- Across the five-year window, Minority Interest sank 49.94% in 2023 and surged 1575.64% in 2025, its largest moves.
- Sanofi's Minority Interest stood at $400.4 million in 2021, then slipped by 6.23% to $375.5 million in 2022, then dropped by 10.3% to $336.8 million in 2023, then climbed by 11.06% to $374.0 million in 2024, then soared by 52.5% to $570.4 million in 2025.
- The last three Minority Interest figures came in at $570.4 million (Q4 2025), $306.8 million (Q2 2025), and $374.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn |
| 10 | Sanofi | - | - | 9.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 570.38 Mn |
| Jun 30, 2025 | 306.76 Mn |
| Dec 31, 2024 | 374.01 Mn |
| Jun 30, 2024 | 18.31 Mn |
| Dec 31, 2023 | 336.77 Mn |
| Jun 30, 2023 | 28.31 Mn |
| Dec 31, 2022 | 375.45 Mn |
| Jun 30, 2022 | 56.55 Mn |
| Dec 31, 2021 | 400.39 Mn |
| Jun 30, 2021 | 24.09 Mn |
| Dec 31, 2020 | 174.07 Mn |
| Jun 30, 2020 | 22.03 Mn |
| Dec 31, 2019 | 192.60 Mn |
| Jun 30, 2019 | 16.85 Mn |
| Dec 31, 2018 | 181.48 Mn |
| Mar 31, 2018 | 202.71 Mn |
| Dec 31, 2017 | 198.99 Mn |
| Jun 30, 2017 | 177.03 Mn |
| Dec 31, 2016 | 183.55 Mn |
| Dec 31, 2015 | 176.47 Mn |